RT Journal Article
SR Electronic
T1 The SARS-CoV-2 infection among students in the University of Porto: a cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.14.21264978
DO 10.1101/2021.10.14.21264978
A1 Paula Meireles
A1 Joana Pinto Costa
A1 Maria João Novais
A1 Daniela Miranda
A1 Mariana Mendes Lopes
A1 Milton Severo
A1 Henrique Barros
YR 2021
UL http://medrxiv.org/content/early/2021/10/18/2021.10.14.21264978.abstract
AB Introduction Incidence based on notified cases of SARS-CoV-2 infection underestimates the real extension of the infection. We aimed to quantify SARS-CoV-2 specific antibodies’ seroprevalence among University students in Porto.Methods A rapid point of care testing for SARS-CoV-2 specific immunoglobulin (Ig) M and IgG antibodies was performed, and a questionnaire was applied to the 6512 voluntary students from September to December 2020. We computed the apparent IgM, IgG and IgM or IgG prevalence, and the true prevalence and 95% credible intervals (95% CI) using Bayesian inference.Results We found an apparent prevalence (IgM or IgG) of 9.7%, the true prevalence being 7.9% (95% CI 4.9-11.1). Prevalence was significantly higher among males (10.9% vs 9.2%), international students (18.1% vs 10.4% local vs 8.8% nationally displaced) and increased with age. Those with a known risk contact, that experienced quarantine, had symptoms, or a previous negative molecular test had a higher seroprevalence. Of the 91 (1.4%) students who reported a molecular diagnosis, 86.7% were reactive for IgM or IgG.Conclusion Based on immunological evidence infection was 5.6 times more frequent than if based on a molecular diagnosis. The higher seroprevalence among male, older, and international students emphasizes the importance of identifying particular groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by University of Porto and supported by national funds of Fundacao para a Ciencia e Tecnologia (FCT), under the scope of the project UIDB/04750/2020 Research Unit of Epidemiology, Institute of Public Health of the University of Porto (EPIUnit). Joana Costa was the recipient of PhD grant 2020.08562.BD cofunded by the national funds of FCT and the Fundo Social Europeu (FSE). The funding source had no role in the work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Institute of Public Health of the University of Porto gave ethical approval for this work (ID 20154).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.